Zealand Pharma A/SZealand Pharma A/SZealand Pharma A/S

Zealand Pharma A/S

No trades
No trades

Fundamentals and stats

EPS and revenue snapshot

In the last quarter, the company reported −5.58 DKK per share, beating the −8.85 DKK estimate by 36.97%. Revenue for the same period reached ‪34.00 M‬ DKK, despite the estimate of ‪18.23 M‬ DKK. For the next quarter, analysts expect 0.94 DKK in earnings per share and ‪4.54 B‬ DKK in revenue.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise